+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021 - Product Thumbnail Image

Transthyretin Amyloid Cardiomyopathy - Pipeline Inisght, 2021

  • Clinical Trials
  • September 2021
  • 60 Pages
  • Global
From
From
Prescription Drugs Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Prescription Drugs Market - Forecasts from 2025 to 2030

  • Report
  • December 2024
  • 155 Pages
  • Global
From
From
Human Insulin Drugs Market in Brazil 2024-2028 - Product Thumbnail Image

Human Insulin Drugs Market in Brazil 2024-2028

  • Report
  • December 2023
  • 142 Pages
  • Brazil
From
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Cardiometabolic Diseases Market Report 2025 - Product Thumbnail Image

Cardiometabolic Diseases Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Global Markets for Insulin Drug and Delivery Technologies - Product Thumbnail Image

Global Markets for Insulin Drug and Delivery Technologies

  • Report
  • August 2022
  • 120 Pages
  • Global
From
From
Cancer Monoclonal Antibodies Market Report 2025 - Product Thumbnail Image

Cancer Monoclonal Antibodies Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
From
Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Glucagon-Like Peptide (GLP) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Global Markets for Bioengineered Protein Drugs - Product Thumbnail Image

Global Markets for Bioengineered Protein Drugs

  • Report
  • March 2023
  • 185 Pages
  • Global
From
Loading Indicator